Pacira BioSciences (PCRX) Accounts Payables (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Accounts Payables of $14.0 million for Q1 2026, down 39.53% year-over-year from $23.2 million in Q1 2025, and down 7.51% quarter-over-quarter from $15.2 million in Q4 2025.
Pacira BioSciences (PCRX) Accounts Payables (2010 - 2026) Analysis & Trends
Pacira BioSciences' Accounts Payables history runs 17 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 39.53% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $14.0 million (down 39.53% YoY), while the FY2025 annual figure was $15.2 million, down 20.82% from the prior year.
- Accounts Payables for Q1 2026 stood at $14.0 million, down from $15.2 million in the prior quarter.
- The five-year high for Accounts Payables was $30.1 million in Q2 2025, with the low at $9.0 million in Q1 2024.
- The 5-year median for Accounts Payables is $16.5 million (2023), against an average of $17.5 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 47.96% in 2024, then jumped 157.98% in 2025.
- Pacira BioSciences' Accounts Payables stood at $15.2 million in 2022, then gained by 3.14% to $15.7 million in 2023, then advanced by 21.88% to $19.1 million in 2024, then decreased by 20.82% to $15.2 million in 2025, then decreased by 7.51% to $14.0 million in 2026.
- Business Quant data shows PCRX's Accounts Payables at $14.0 million in Q1 2026, $15.2 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | Pacira BioSciences | 945.31 Mn | 694.28 Mn | 148.24 Mn | 17.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.51 Mn |
| Mar 31, 2026 | 14.01 Mn |
| Dec 31, 2025 | 15.15 Mn |
| Sep 30, 2025 | 17.69 Mn |
| Jun 30, 2025 | 30.12 Mn |
| Mar 31, 2025 | 23.17 Mn |
| Dec 31, 2024 | 19.13 Mn |
| Sep 30, 2024 | 19.37 Mn |
| Jun 30, 2024 | 18.73 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 15.70 Mn |
| Sep 30, 2023 | 16.51 Mn |
| Jun 30, 2023 | 24.21 Mn |
| Mar 31, 2023 | 17.26 Mn |
| Dec 31, 2022 | 15.22 Mn |
| Sep 30, 2022 | 12.93 Mn |
| Jun 30, 2022 | 13.98 Mn |
| Mar 31, 2022 | 14.84 Mn |
| Dec 31, 2021 | 10.54 Mn |
| Sep 30, 2021 | 7.90 Mn |